The executive president of Laboratorios Rubió, Carlos Rubió, analyses the fundamentals behind the Catalan company’s double-digit growth, its international expansion plan, which includes the United States, the doubling of capacity at their Castellbisbal plant, and the challenges of the Spanish market. A producer of hydroxychloroquine, Laboratorios Rubió experienced skyrocketing demand during the early phases of the pandemic as well as significant disruption to its regular operations.
The main reason for the company’s financial success is our driven and loyal workforce which has gone above and beyond during the COVID-19 crisis, in addition to strong partnerships and new ventures
